• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 33
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • Tagged with
  • 62
  • 55
  • 15
  • 14
  • 13
  • 12
  • 10
  • 9
  • 9
  • 8
  • 8
  • 8
  • 7
  • 7
  • 7
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
31

JMJD3 acts as a tumor suppressor by disrupting cytoskeleton in pancreatic ductal adenocarcinoma cells. / CUHK electronic theses & dissertations collection

January 2013 (has links)
Xiao, Zhangang. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2013. / Includes bibliographical references (leaves 118-131). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts also in Chinese.
32

Uso de inibidores das histonas deacetilases na transferência nuclear de células somáticas em bovinos / Use of histone deacetylases inhibitors in bovine somatic cell nuclear transfer

Sangalli, Juliano Rodrigues 07 July 2016 (has links)
A clonagem de mamíferos por transferência nuclear de células somáticas (TNCS) ainda é afetada pela baixa eficiência. As modificações epigenéticas estabelecidas durante o processo de diferenciação celular estão entre os principais fatores. Uma vez que estas modificações atuam como barreiras epigenéticas restringindo a reprogramação do núcleo somático. Considerando isso, a maioria dos fatores que promovem a descondensação da cromatina, incluindo os inibidores das Histonas Deacetilases (HDACis), tem sido demonstrado aumentarem a eficiência da reprogramação nuclear, tornando o seu uso comum para melhorar as taxas da TNCS. Neste trabalho, nós testamos dois inibidores das histonas deacetilases: o Ácido Valpróico (VPA) e o Ácido β-Hidróxibutírico (BOHB), sendo um farmacológico e o outro um metabólito endógeno na TNCS. Nosso objetivo era testar se o tratamento de células doadoras de núcleo ou zigotos com estes HDACis melhoravam o desenvolvimento de embriões bovinos clonados. Em relação ao VPA, nós observamos que o tratamento de fibroblastos com o VPA aumentou a acetilação das histonas e a expressão de genes importantes para o desenvolvimento como IGF2R e PPARGC1A. Entretanto, quando as células tratadas foram usadas como doadoras de núcleo, não foi observado diferença nos níveis de acetilação das H3K9 entre os grupos. Além disso, as alterações foram rapidamente removidas após a transferência nuclear. Em relação as taxas de desenvolvimento, o uso de células tratadas como doadoras de núcleo não resultou em diferença durante o desenvolvimento pré- e pós-implantacional. Em relação ao BOHB, nós executamos um série de experimentos para testar se esta molécula age como um inibidor das HDACs em bovinos. Nós observamos que fibroblastos tratados com BOHB apresentam aumento nos níveis globais de H3K9ac. O tratamento altera a expressão de genes importantes como os transportadores de glicose e a enzima chave no metabolismo lipídico SCD. Também, nós demonstramos que este metabólito é capaz de alterar uma marca epigenética em zigotos clonados, que persiste até o estágio de blastocisto. Entretanto, o tratamento dos zigotos com este metabólito endógeno não aumentou a taxa de desenvolvimento pré-implantacional, embora tenha alterado a expressão de um fator de transcrição que protege embriões contra estresse oxidativo, o FOXO3a. O tratamento de zigotos partenogenéticos com BOHB não afetou o desenvolvimento embrionário, nem a produção de ATP, sugerindo que o BOHB não apresenta efeitos tóxicos como anteriormente pensado. Concluindo, os resultados deste trabalho mostram que a inibição das HDACs através de uma molécula farmacológica ou um metabólito endógeno, não aumenta a eficiência da TNCS em bovinos. Entretanto, aqui nós mostramos que o corpo cetônico BOHB pode ser um elo de ligação entre o ambiente extracelular e a regulação do metabolismo. E serve como um modelo in vitro para testar como distúrbios metabólicos como a cetose afeta o metabolismo e epigenoma celular e embrionário em bovinos / Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by the low efficiency. The epigenetic marks established during the cell differentiation process are among the main cause. These modifications act as a barrier restricting the nuclear reprogramming process of somatic nuclei. Based on this, molecules that promotes chromatin decondensing, including Histone Deacetylases inhibitors (HDACis), has been demonstrated increase the efficiency of nuclear reprogramming, making their use common on SCNT procedure. Herein, we tested two histone deacetylase inhibitors: Valproic Acid and β-hydroxybutyric Acid, the former a pharmacological drug and the latter, an endogenous metabolite on SCNT. Our objective was to test whether the donor cells treatment or zygotes with these HDACis improve the bovine cloned embryos development. Regarding the VPA, we observed that fibroblasts treatment with VPA increases the histone acetylation and expression of developmentally important genes such as IGF2R and PPARGC1A. However, when treated cells were used as nuclear donors, we did not observe difference on H3K9ac levels between the groups. Moreover, the alterations were quickly removed after SCNT. Regarding the developmental rates, the use of treated cells as nuclear donors did not affect the pre- and post-implantation development. In the second experiment, we used the BOHB in a series of experiments to test whether this molecule acts as a histone deacetylase inhibitor in bovines. We observed that treatment of fibroblasts with BOHB increased the global levels of H3K9ac. Also, treatment alters the expression of important genes such as glucose transporters and a key enzyme regulating lipid synthesis. Additionally, we demonstrated that this metabolite affect at least one epigenetic mark in cloned zygotes, that lasts until the blastocyst stage. However, zygote treatment with this endogenous metabolite did not increase the pre-implantation developmental rates, albeit increased the expression of a transcription factor that protects cells against oxidative stress, the FOXO3a. Treatment of parthenogenetic embryos with BOHB did not affect the embryo development, neither ATP production, suggesting that BOHB is not toxic as previously believed. Concluding, the results presented here shows that the HDAC inhibition through a pharmacological compound or an endogenous metabolite did not increase the efficiency of bovine SCNT. However, here we showed that the ketone body BOHB might be a nexus between the extracellular environment and the cellular metabolism. Also, it can used as a in vitro model to interrogate questions about does metabolic disturbances such as ketosis in cattle affects the epigenome and cellular metabolism in bovines
33

Regulation of the transcription factor GATA-3 within T cells - Involvement of SIRT1, a class III histone deacetylase

Mari, Nathalie 17 October 2008 (has links)
Within the lymphocyte lineage, GATA-3 is a major transcription factor implicated in the regulation of Th1/Th2 differentiation by promoting the expression of the Th2 cytokines, such as IL-4, IL-5, IL-10 and IL-13. Although the role of GATA-3 in the development of the Th2 lineage has been extensively described in the literature, the molecular mechanisms underlying its activity remain to be clarified. Here, we investigated whether GATA-3 might be regulated by reversible acetylation. In vivo, GATA-3 associates with class I and III HDACs. Biochemical studies unraveled the specific association of GATA-3 with the class III member SIRT1. Association with SIRT1 leads to the inhibition of GATA-3-induced IL-5 transcription. Using siRNA, we further show that SIRT1 promotes destabilization of GATA-3. Interestingly, nicotinamide, a specific inhibitor of SIRTs had no effect on the ability of SIRT1 to destabilize GATA-3 and to repress its transcriptional activity. In addition, a catalytic-defective mutant of SIRT1 (H363Y) shows similar effects to wild-type SIRT1, demonstrating that the deacetylase activity of SIRT1 is not required for its regulation of GATA-3. For the first time, our study indicates that SIRT1 is functionally linked to GATA-3. Moreover, our results also suggest that some important SIRT1 functions may not require its deacetylase activity.
34

Caractérisation des sirtuines de Schistosoma mansoni : cibles thérapeutiques potentielles

Lancelot, Julien 13 December 2013 (has links) (PDF)
La schistosomiase représente actuellement la seconde endémie parasitaire mondiale après le paludisme. Annuellement, cette pathologie est responsable de 280 000 décès et 700 millions d'individus y sont exposés dans 74 pays à travers le monde. Actuellement, le traitement de la schistosomiase repose sur l'utilisation d'un seul médicament, le Praziquantel®. Ainsi, le développement de nouveaux médicaments est devenu une priorité absolue pour l'OMS. Dans cette étude, notre objectif a été d'identifier de nouvelles cibles thérapeutiques afin de développer de nouveaux précurseurs de médicaments. Au cours de ce projet, nous avons focalisé nos recherches sur les enzymes impliquées dans la modification des histones et plus particulièrement sur les sirtuines, qui sont des lysines désacétylases NAD+ dépendantes.Dans une première partie, nous avons caractérisé 5 orthologues de sirtuines de mammifères chez Schistosoma mansoni (SmSirt1, 2, 5, 6 et 7). De plus, nous avons étudié le potentiel des sirtuines comme cibles thérapeutiques pour le traitement de la schistosomiase en évaluant la toxicité d'inhibiteurs génériques de sirtuines humaines sur des parasites maintenus en culture. Ainsi, nous avons montré que les inhibiteurs de sirtuines humaines affectent in vitro la viabilité des schistosomules ainsi que la stabilité de l'accouplement et la production d'oeufs des vers adultes. De plus, ces inhibiteurs induisent des changements morphologiques de l'appareil génital du ver femelle.Dans une seconde partie, nous avons entrepris d'étudier plus spécifiquement le rôle de SmSirt2 en tant que cible thérapeutique. Ainsi, l'expression de la protéine recombinante en bactérie E. coli (collaboration: C. Romier, IGBMC, Illkirch) ainsi que l'optimisation d'un dosage fluorimétrique nous ont permis de montrer que SmSirt2 présente une activité lysine désacétylase in vitro (collaboration: M. Jung, Université Albert-Ludwigs, Freibourg). De plus, l'utilisation de ce dosage nous a permis de mettre en place le criblage à haut débit d'une chimiothèque de plus de 80 000 composés afin d'identifier de nouvelles molécules inhibitrices de l'enzyme SmSirt2 (collaboration: J. Schultz, Kancera AB, Stockholm). Les composés les plus prometteurs, ont été testés in vitro sur des parasites en culture. Les résultats obtenus démontrent que les inhibiteurs de SmSirt2 affectent également la viabilité des schistosomules ainsi que la stabilité de l'accouplement et la production d'oeufs des vers adultes.Dans une dernière partie, nous avons mis en place un criblage d'une banque d'ADNc de vers adultes par la technique du double hybride en levure dans le but d'identifier les partenaires protéiques de Sirt1 chez S. mansoni. L'analyse partielle des résultats nous a permis de mettre en évidence que SmSirt1 interagit avec plusieurs protéines impliquées dans la régulation des gènes chez le schistosome. Au cours de ce projet, nous avons également développé et optimisé un protocole permettant d'étudier l'activité enzymatique de SmSirt1 par injection d'ARNm dans des ovocytes de Xénope. Ainsi, nous avons pu montrer que le sirtinol et la salermide, deux inhibiteurs de Sirt1 humaine, présentent également une activité inhibitrice sur l'enzyme du parasite (collaboration: K. Cailliau, Université des Sciences et Technologies, Lille).L'ensemble des résultats obtenus au cours de ce projet de thèse suggère que les sirtuines sont des cibles thérapeutiques potentielles dans le traitement de la schistosomiase. Parmi les 5 orthologues identifiés chez S. mansoni, SmSirt2 semble une cible prometteuse. De plus, le criblage à haut débit que nous avons réalisé sur l'enzyme recombinante a permis d'identifier des molécules qui, après bio-optimisation, pourront être des candidats médicaments. Pour finir, ces résultats participent à une meilleure compréhension du rôle biologique des sirtuines chez S. mansoni et plus particulièrement sur leur implication dans la survie et la reproduction du parasite.
35

Alcohol induced histone acetylation mediated by histone acetyl transferase GCN5 in liver

Choudhury, Mahua, Shukla, Shivendra D. January 2008 (has links)
The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from PDF of title page (University of Missouri--Columbia, viewed on April 6, 2010). Vita. Thesis advisor: Shivendra D. Shukla. "August 2008" Includes bibliographical references
36

Uso de inibidores das histonas deacetilases na transferência nuclear de células somáticas em bovinos / Use of histone deacetylases inhibitors in bovine somatic cell nuclear transfer

Juliano Rodrigues Sangalli 07 July 2016 (has links)
A clonagem de mamíferos por transferência nuclear de células somáticas (TNCS) ainda é afetada pela baixa eficiência. As modificações epigenéticas estabelecidas durante o processo de diferenciação celular estão entre os principais fatores. Uma vez que estas modificações atuam como barreiras epigenéticas restringindo a reprogramação do núcleo somático. Considerando isso, a maioria dos fatores que promovem a descondensação da cromatina, incluindo os inibidores das Histonas Deacetilases (HDACis), tem sido demonstrado aumentarem a eficiência da reprogramação nuclear, tornando o seu uso comum para melhorar as taxas da TNCS. Neste trabalho, nós testamos dois inibidores das histonas deacetilases: o Ácido Valpróico (VPA) e o Ácido β-Hidróxibutírico (BOHB), sendo um farmacológico e o outro um metabólito endógeno na TNCS. Nosso objetivo era testar se o tratamento de células doadoras de núcleo ou zigotos com estes HDACis melhoravam o desenvolvimento de embriões bovinos clonados. Em relação ao VPA, nós observamos que o tratamento de fibroblastos com o VPA aumentou a acetilação das histonas e a expressão de genes importantes para o desenvolvimento como IGF2R e PPARGC1A. Entretanto, quando as células tratadas foram usadas como doadoras de núcleo, não foi observado diferença nos níveis de acetilação das H3K9 entre os grupos. Além disso, as alterações foram rapidamente removidas após a transferência nuclear. Em relação as taxas de desenvolvimento, o uso de células tratadas como doadoras de núcleo não resultou em diferença durante o desenvolvimento pré- e pós-implantacional. Em relação ao BOHB, nós executamos um série de experimentos para testar se esta molécula age como um inibidor das HDACs em bovinos. Nós observamos que fibroblastos tratados com BOHB apresentam aumento nos níveis globais de H3K9ac. O tratamento altera a expressão de genes importantes como os transportadores de glicose e a enzima chave no metabolismo lipídico SCD. Também, nós demonstramos que este metabólito é capaz de alterar uma marca epigenética em zigotos clonados, que persiste até o estágio de blastocisto. Entretanto, o tratamento dos zigotos com este metabólito endógeno não aumentou a taxa de desenvolvimento pré-implantacional, embora tenha alterado a expressão de um fator de transcrição que protege embriões contra estresse oxidativo, o FOXO3a. O tratamento de zigotos partenogenéticos com BOHB não afetou o desenvolvimento embrionário, nem a produção de ATP, sugerindo que o BOHB não apresenta efeitos tóxicos como anteriormente pensado. Concluindo, os resultados deste trabalho mostram que a inibição das HDACs através de uma molécula farmacológica ou um metabólito endógeno, não aumenta a eficiência da TNCS em bovinos. Entretanto, aqui nós mostramos que o corpo cetônico BOHB pode ser um elo de ligação entre o ambiente extracelular e a regulação do metabolismo. E serve como um modelo in vitro para testar como distúrbios metabólicos como a cetose afeta o metabolismo e epigenoma celular e embrionário em bovinos / Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by the low efficiency. The epigenetic marks established during the cell differentiation process are among the main cause. These modifications act as a barrier restricting the nuclear reprogramming process of somatic nuclei. Based on this, molecules that promotes chromatin decondensing, including Histone Deacetylases inhibitors (HDACis), has been demonstrated increase the efficiency of nuclear reprogramming, making their use common on SCNT procedure. Herein, we tested two histone deacetylase inhibitors: Valproic Acid and β-hydroxybutyric Acid, the former a pharmacological drug and the latter, an endogenous metabolite on SCNT. Our objective was to test whether the donor cells treatment or zygotes with these HDACis improve the bovine cloned embryos development. Regarding the VPA, we observed that fibroblasts treatment with VPA increases the histone acetylation and expression of developmentally important genes such as IGF2R and PPARGC1A. However, when treated cells were used as nuclear donors, we did not observe difference on H3K9ac levels between the groups. Moreover, the alterations were quickly removed after SCNT. Regarding the developmental rates, the use of treated cells as nuclear donors did not affect the pre- and post-implantation development. In the second experiment, we used the BOHB in a series of experiments to test whether this molecule acts as a histone deacetylase inhibitor in bovines. We observed that treatment of fibroblasts with BOHB increased the global levels of H3K9ac. Also, treatment alters the expression of important genes such as glucose transporters and a key enzyme regulating lipid synthesis. Additionally, we demonstrated that this metabolite affect at least one epigenetic mark in cloned zygotes, that lasts until the blastocyst stage. However, zygote treatment with this endogenous metabolite did not increase the pre-implantation developmental rates, albeit increased the expression of a transcription factor that protects cells against oxidative stress, the FOXO3a. Treatment of parthenogenetic embryos with BOHB did not affect the embryo development, neither ATP production, suggesting that BOHB is not toxic as previously believed. Concluding, the results presented here shows that the HDAC inhibition through a pharmacological compound or an endogenous metabolite did not increase the efficiency of bovine SCNT. However, here we showed that the ketone body BOHB might be a nexus between the extracellular environment and the cellular metabolism. Also, it can used as a in vitro model to interrogate questions about does metabolic disturbances such as ketosis in cattle affects the epigenome and cellular metabolism in bovines
37

Analyse fonctionnelle des N-déacétylases de Clostridium difficile / Functional analysis of the N-deacetylases of Clostridium difficile

Coullon, Héloïse 23 November 2018 (has links)
Clostridium difficile est une bactérie anaérobie sporulante responsable de 15 à 25% des diarrhées post-antibiotiques. Les N-déacétylases sont largement distribuées parmi les bactéries à Gram positif et elles sont impliquées dans différentes fonctions de surface. L'analyse du génome de C. difficile montre que 13 gènes codent pour des N-déacétylases potentielles, et nous avons caractérisé l’ensemble de ces N-déacétylases.Le peptidoglycane de la cellule végétative de C. difficile est N-déacétylé sur 93% des glucosamines, et cette modification participe à la résistance de la bactérie au lysozyme, un composant majeur de l’immunité innée. Nous avons identifié les N-déacétylases PgdA, PgdB et PdaV responsables de cette N-déacétylation, et nous avons évalué leur impact au sein de la virulence de C. difficile. Nous avons également défini le rôle de deux N-déacétylases NagA dans le recyclage du peptidoglycane.Le peptidoglycane de la spore, ou cortex, a été analysé lors de ce travail et sa structure chez C. difficile est atypique par rapport au cortex décrit pour d’autres espèces bactériennes. Nous avons défini les N-déacétylases responsables de la N-déacétylation de la glucosamine du cortex. Nous avons également caractérisé les deux N-déacétylases PdaA1 et PdaA2 responsables de la synthèse des δ-lactames, une modification spécifique du cortex, ainsi que leur influence dans la virulence de C. difficile. Dans ce cadre, nous avons montré que les δ-lactames ont un rôle physiologique plus large pour C. difficile que chez Bacillus subtilis. De plus, nous avons identifié deux N-déacétylases potentiellement impliquées dans la synthèse de ce cortex.À travers ces résultats, ce travail apporte de nouvelles connaissances dans le rôle des N-déacétylases bactériennes. / Clostridium difficile is an anaerobic and spore-forming bacteria responsible for 15 to 25% of post-antibiotic diarrhea. N-deacetylases are largely distributed among Gram positive bacteria and are involved in many surface processes. C. difficile genome analysis showed that 13 genes potentially encode N-deacetylases. In this work, we have characterized all of these enzymes.The vegetative cell peptidoglycan of C. difficile is deacetylated on 93% its glucosamine, and this modification is involved in the resistance of C. difficile against lysozyme, a major component of the innate immunity. We identified the N-deacetylases PgdA, PgdB and PdaV responsible for this N-deacetylation, and we assessed their impact on C. difficile virulence. The role of two N-deacetylases involved in peptidoglycan recycling has also been assessed.The spore peptidoglycan, known as the cortex, has also been characterized during this work, and its structure is atypical in C. difficile compared to other bacterial species. We showed that N-deacetylation of the glucosamine is present in the cortex peptidoglycan, and we identified the N-deacetylases responsible for this modification. Additionally, we characterized the N-deacetylases PdaA1 and PdaA2 responsible for the synthesis of muramic-δ-lactams, a cortex specific modification, as well as their impact on C. difficile virulence. In his context, we determined that muramic-δ-lactams have a broader role in C. difficile compared to their role in Bacillus subtilis. Moreover, two N-deacetylases involved in cortex synthesis have been identified.This work adds a contribution in the knowledge of the roles of bacterial N-deacetylases.
38

Histone H2A exogène induit à différenciation et la sénescence des cellules cancéreuses

Hadnagy, Annamaria January 2008 (has links)
Mémoire numérisé par la Division de la gestion de documents et des archives de l'Université de Montréal.
39

Studium kvasinkového kmene BR-S s delecí genu SIR2 / Studies of S. cerevisiae BR-S strain with deletion of SIR2 gene

Novotná, Pavla January 2016 (has links)
Yeasts are unicellular eukaryotic microorganisms, capable of forming of organised multicellular communities, the colonies. Many yeast strains possess a characteristic colony morphology under defined living conditions. Another feature typical for many feral and pathogenic yeast strains is the ability to switch their morphotype. This phenomenon, called the phenotypic switching, contributes to a rapid adaptation to the changing harmful environment and is often connected with changes of the stress resistance or with the changes of virulence of pathogenic yeasts. Phenotypic switching can be observed even in non-pathogenic yeast Saccharomyces cerevisiae. The strain BR-F, isolated from nature, switches under laboratory conditions from fluffy to smooth morphology of the strain BR-S. This phenotypic switch is accompanied by broad changes in the phenotype. Transcriptome analyses of the strains BR-F and BR-S have shown, among others, changes in expression of the subtelomeric genes that are under control of the histone acetylases and deacetylases. My work was aimed to the histone deacetylase Sir2p, which could influence the phenotypic switching in Saccharomyces cerevisiae. The sir2 deletion mutant of the strain BR-S, prepared in our laboratory, was used for my studies. The results show, that the strain BR-S...
40

Studium funkce vybraných genů v koloniích divokých kmenů kvasinek / Study of the function of selected genes in the colonies of wild yeast strains

Tarabová, Eva January 2013 (has links)
Saccharomyces cerevisiae strains isolated from the wild are able to exhibit multicellular social behaviour and to form complex structured colonies resembling in many properties highly resistant biofilms of pathogenic yeasts. The capability of phenotypic variability, i.e. high frequency transition between two or more different phenotypes, is another feature typical for the wild yeast strains. Such phenotypic changes are in case of pathogenic yeast often connected with changes in virulence and resistance to stress and antifungal treatment. Long-term cultivation of the wild yeast strains under laboratory conditions leads to their domestication, i.e. transition to smooth colonies and loss of some features typical for structured colonies. This process is, similarly to phenotypic switching, accompanied by significant changes in gene expression and global change of colony lifestyle. Mechanisms underlying yeast phenotypic transitions are ascribed to epigenetic regulation of gene expression via transcriptional silencing conferred by histone deacetylases. This work deals with the study of such mechanisms using knock-outs of selected genes with putative function in formation of structured colonies in wild and domesticated strains. The achieved results show, that NAD+-dependent histone deacetylase Sir2p influences...

Page generated in 0.0857 seconds